Quarterly report [Sections 13 or 15(d)]

Accrued and Other Current Liabilities

v3.25.3
Accrued and Other Current Liabilities
9 Months Ended
Sep. 30, 2025
Payables and Accruals [Abstract]  
Accrued and Other Current Liabilities

4. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2025

 

 

2024

 

Manufacturing and other research and development services

 

$

6,160

 

 

$

2,255

 

Clinical trial research and development services

 

 

3,087

 

 

 

1,236

 

General and administrative services

 

 

205

 

 

 

342

 

Compensation expense

 

 

6,764

 

 

 

8,315

 

Other

 

 

30

 

 

 

40

 

 

 

$

16,246

 

 

$

12,188